Rheumatoid arthritis

Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study

Rheumatology (Oxford)Published Prospective observational cohort study

Authors' conclusion

MTX-based regimens associated with a reduced risk of SI compared with other strategies. Patient-level and disease-related factors at diagnosis are important predictors of SI in individuals with new RA.

Study context

Population
Adults in England and Wales with new diagnoses of RA, 2018–2023, recruited to the National Early Inflammatory Arthritis Audit1,307 serious infections (SI) events
Participants
17,472 adults
Exposure
MTX-based strategies vs other csDMARDs; CS vs no CS
  • MTX-basedn = 10,997
  • Other csDMARDsn = 4,540reference
Outcome
SI events: infections requiring hospitalization or resulting in death
Methodological detailsCox proportional hazards models, confounder-adjusted
  • Cox proportional hazards models
  • Confounder-adjusted

Main finding

As reported in the abstract

SI events
Each group vs other csDMARDsAdjusted hazard ratio (95% CI)
MTX-based
0.72(0.63–0.82)
CShigher risk in unadjusted models; no longer significant after adjustment
0.99(0.87–1.12)
SI events, overall
1307
SI incidence rates (IR) per 100 person-years
3.02 (95% CI 2.86-3.19)

Observational data: associations, not effects.

Further findings

SI-related mortality

Cases
311
IR per 100 person-years
0.69 (95% CI 0.61-0.77)

Predictors of SI

Increase in SI risk per one-unit increase in baseline DAS28
10%
Increasing age, current/ex-smoking, comorbidity, seropositivity and high DAS28 associated with increased SI incidence

Original publication

Risk of infection in patients with early inflammatory arthritis: results from a large UK prospective observational cohort study. Rheumatology (Oxford). Published 5 June 2025. doi:10.1093/rheumatology/keaf312

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.